Your browser doesn't support javascript.
loading
The N-terminal polypeptide derived from vMIP-II exerts its antitumor activity in human breast cancer through CXCR4/miR-7-5p/Skp2 pathway.
Wang, Hai-Feng; Dong, Zheng-Yuan; Yan, Lei; Yang, Shuo; Xu, He-Nan; Chen, Su-Lian; Wang, Wen-Rui; Yang, Qing-Ling; Chen, Chang-Jie.
Afiliação
  • Wang HF; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui, China.
  • Dong ZY; Department of Clinical Laboratory, Huaibei City People's Hospital, Huaibei, Anhui, China.
  • Yan L; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui, China.
  • Yang S; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui, China.
  • Xu HN; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui, China.
  • Chen SL; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui, China.
  • Wang WR; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui, China.
  • Yang QL; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui, China.
  • Chen CJ; Department of Biotechnology, Bengbu Medical College, Bengbu, Anhui, China.
J Cell Physiol ; 235(12): 9474-9486, 2020 12.
Article em En | MEDLINE | ID: mdl-32372405
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Receptores CXCR4 / MicroRNAs / Transição Epitelial-Mesenquimal Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Receptores CXCR4 / MicroRNAs / Transição Epitelial-Mesenquimal Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China